Catalyst Edge · Scanner · Tickers · ACAD
CATALYST DOSSIER · UPDATED 2026-11-10

$ACAD

biotech · convergence -7 · conviction WATCH
Convergence Score
-7
Conviction
WATCH
Signals Firing
8
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $ACAD?

ACAD -7 WATCH biotech

Quantitative

  • Net Income (CY2026Q2): $31.5M (+18.1% YoY)

Catalysts

  • Clinical trial milestone: ACP-204 in Adults With Alzheimer's Disease Psychosis

Risks

  • Auditor change / restatement: restatement on

Bear case

  • Multiple compression: If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis

Sympathy basket (cerebro)

  • QBTS via tech r=+0.97 sympathetic (score 25)
  • INVE via tech r=+0.97 sympathetic (score 24)
  • GCTS via semis r=+0.91 sympathetic (score 28)
  • NVDA via semis r=+0.91 sympathetic (score 27)
  • MOD via consumer r=+0.81 sympathetic (score 23)
  • LINC via consumer r=+0.81 sympathetic (score 18)

Signals Firing

sec_fdaauto_macro_adp_payrollsauto_macro_banrep_colombiaauto_macro_bls_employmentauto_macro_credit_spreadsauto_macro_durable_goodsauto_macro_options_gexauto_macro_yield_curve
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Sympathy Basket

Tickers Catalyst Edge tracks as moving with this name. Cross-correlation derived from sector + score-cohort proximity.

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.

You came here for ACAD. You found it after it moved, the same way everyone else did.

$99 once — every ticker on this site ranked before the open.

Review the methodology and limitations and the dated audit. An intraday price touch is not trading profit.

  1. Click Become a Founding Member below.
  2. Pay $99 once — not monthly, not ever again.
  3. You keep every future release at that price. Tomorrow's ranked list lands at 3:30 AM ET, before the open.
Become a Founding Member — $99 once

One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →

Optional product-learning preferences